TELA Bio
TELA
67 hedge funds and large institutions have $223M invested in TELA Bio in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 11 closing their positions.
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
85% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 13
26% more funds holding
Funds holding: 53 → 67 (+14)
24% more capital invested
Capital invested by funds: $180M → $223M (+$43.2M)
22% more call options, than puts
Call options by funds: $71K | Put options by funds: $58K
2.13% more ownership
Funds ownership: 88.07% → 90.21% (+2.1%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$17.6M |
| 2 |
BlackRock
New York
|
+$10.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.32M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.94M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$3.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.04M |
| 2 |
O
OrbiMed
New York
|
-$1.96M |
| 3 |
KIA
Knollwood Investment Advisory
Hunt Valley,
Maryland
|
-$1.22M |
| 4 |
Millennium Management
New York
|
-$1.11M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$732K |
TELA Hedge Fund Activity: Q2 2023 in Review
67 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2023, worth a combined $223M — up 24% from $180M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new TELA positions and 11 closed out — a net gain of 14 holders — while 24 added to existing stakes and 13 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $17.6M. The largest seller was Opaleye Management, cutting an estimated $5.04M.
- 67 institutional investors held TELA Bio (TELA) as of Q2 2023, up from 53 in Q1 2023.
- Funds reported $223M of TELA Bio stock for Q2 2023, up 24% quarter-over-quarter.
- 25 funds opened new TELA Bio positions in Q2 2023 and 11 closed out, a net change of +14 holders.
- The largest TELA Bio buyer in Q2 2023 was First Light Asset Management, an estimated $17.6M added.
- The largest TELA Bio seller in Q2 2023 was Opaleye Management, an estimated $5.04M sold.
Based on aggregated 13F filings for Q2 2023.